Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Jan;79(1):1–6. doi: 10.1172/JCI112768

Circulating and tissue angiotensin systems.

D J Campbell
PMCID: PMC423969  PMID: 3025255

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acker G. M., Galen F. X., Devaux C., Foote S., Papernik E., Pesty A., Menard J., Corvol P. Human chorionic cells in primary culture: a model for renin biosynthesis. J Clin Endocrinol Metab. 1982 Nov;55(5):902–909. doi: 10.1210/jcem-55-5-902. [DOI] [PubMed] [Google Scholar]
  2. Aguilera G., Schirar A., Baukal A., Catt K. J. Circulating angiotensin II and adrenal receptors after nephrectomy. Nature. 1981 Feb 5;289(5797):507–509. doi: 10.1038/289507a0. [DOI] [PubMed] [Google Scholar]
  3. Arakawa K., Yuki M., Ikeda M. Chemical identity of tryptensin with angiotensin. Biochem J. 1980 Jun 1;187(3):647–653. doi: 10.1042/bj1870647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blumberg A. L., Denny S. E., Marshall G. R., Needleman P. Blood vessel-hormone interactions: angiotensin, bradykinin, and prostaglandins. Am J Physiol. 1977 Mar;232(3):H305–H310. doi: 10.1152/ajpheart.1977.232.3.H305. [DOI] [PubMed] [Google Scholar]
  5. Boucher R., Demassieux S., Garcia R., Genest J. Tonin, angiotensin II system. A review. Circ Res. 1977 Oct;41(4 Suppl 2):26–29. doi: 10.1161/01.res.41.4.26. [DOI] [PubMed] [Google Scholar]
  6. Bouhnik J., Fehrentz J. A., Galen F. X., Seyer R., Evin G., Castro B., Menard J., Corvol P. Immunologic identification of both plasma and human renal inactive renin as prorenin. J Clin Endocrinol Metab. 1985 Feb;60(2):399–401. doi: 10.1210/jcem-60-2-399. [DOI] [PubMed] [Google Scholar]
  7. Brown A. J., Casals-Stenzel J., Gofford S., Lever A. F., Morton J. J. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol. 1981 Sep;241(3):H381–H388. doi: 10.1152/ajpheart.1981.241.3.H381. [DOI] [PubMed] [Google Scholar]
  8. Brunner H. R., Waeber B., Nussberger J., Schaller M. D., Gomez H. J. Long-term clinical experience with enalapril in essential hypertension. J Hypertens Suppl. 1983 Oct;1(1):103–107. [PubMed] [Google Scholar]
  9. Campbell D. J., Habener J. F. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest. 1986 Jul;78(1):31–39. doi: 10.1172/JCI112566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Catt K. J., Cain M. C. Measurement of angiotensin II in blood. Lancet. 1967 Nov 11;2(7524):1005–1007. doi: 10.1016/s0140-6736(67)90285-1. [DOI] [PubMed] [Google Scholar]
  11. Catt K. J., Cain M. D., Coghlan J. P., Zimmet P. Z., Cran E., Best J. B. Metabolism and blood levels of angiotensin II in normal subjects, renal disease, and essential hypertension. Circ Res. 1970 Oct;27(Suppl):177+–177+. [PubMed] [Google Scholar]
  12. Catt K. J., Cran E., Zimmet P. Z., Best J. B., Cain M. D., Coghlan J. P. Angiotensin II blood-levels in human hypertension. Lancet. 1971 Mar 6;1(7697):459–464. doi: 10.1016/s0140-6736(71)91085-3. [DOI] [PubMed] [Google Scholar]
  13. Celio M. R., Inagami T. Angiotensin II immunoreactivity coexists with renin in the juxtaglomerular granular cells of the kidney. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3897–3900. doi: 10.1073/pnas.78.6.3897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Clappison B. H., Anderson W. P., Johnston C. I. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. Kidney Int. 1981 Nov;20(5):615–620. doi: 10.1038/ki.1981.184. [DOI] [PubMed] [Google Scholar]
  15. Crantz F. R., Swartz S. L., Hollenberg N. K., Moore T. J., Dluhy R. G., Williams G. H. Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension. Hypertension. 1980 Sep-Oct;2(5):604–609. doi: 10.1161/01.hyp.2.5.604. [DOI] [PubMed] [Google Scholar]
  16. De Fernández M. T., Paladini A. C., Delius A. E. Isolation and identification of a pepsitensin. Biochem J. 1965 Nov;97(2):540–546. doi: 10.1042/bj0970540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Derkx F. H., Wenting G. J., Man in 't Veld A. J., Verhoeven R. P., Schalekamp M. A. Control of enzymatically inactive renin in man under various pathological conditions: implications for the interpretation of renin measurements in peripheral and renal venous plasma. Clin Sci Mol Med. 1978 May;54(5):529–538. doi: 10.1042/cs0540529. [DOI] [PubMed] [Google Scholar]
  18. DiNicolantonio R., Dusting G. J., Hutchinson J. S., Mendelsohn F. A. Failure of aspirin to modify the hypotensive action of captopril in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1981 Jul;8(4):345–349. doi: 10.1111/j.1440-1681.1981.tb00738.x. [DOI] [PubMed] [Google Scholar]
  19. Dorer F. E., Lentz K. E., Kahn J. R., Levine M., Skeggs L. T. A comparison of the substrate specificities of cathepsin D and pseudorenin. J Biol Chem. 1978 May 10;253(9):3140–3142. [PubMed] [Google Scholar]
  20. Dzau V. J., Brenner A., Emmett N., Haber E. Identification of renin and renin-like enzymes in rat brain by a renin-specific antibody. Clin Sci (Lond) 1980 Dec;59 (Suppl 6):45s–47s. doi: 10.1042/cs059045s. [DOI] [PubMed] [Google Scholar]
  21. Fei D. T., Scoggins B. A., Tregear G. W., Coghlan J. P. Angiotensin I, II, and III in sheep. A model of angiotensin production and metabolism. Hypertension. 1981 Nov-Dec;3(6):730–737. doi: 10.1161/01.hyp.3.6.730. [DOI] [PubMed] [Google Scholar]
  22. Fernandez L. A., Twickler J., Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med. 1985 Feb;105(2):141–145. [PubMed] [Google Scholar]
  23. Field L. J., McGowan R. A., Dickinson D. P., Gross K. W. Tissue and gene specificity of mouse renin expression. Hypertension. 1984 Jul-Aug;6(4):597–603. doi: 10.1161/01.hyp.6.4.597. [DOI] [PubMed] [Google Scholar]
  24. Fishman M. C., Zimmerman E. A., Slater E. E. Renin and angiotensin: the complete system within the neuroblastoma x glioma cell. Science. 1981 Nov 20;214(4523):921–923. doi: 10.1126/science.6272392. [DOI] [PubMed] [Google Scholar]
  25. Fordis C. M., Megorden J. S., Ropchak T. G., Keiser H. R. Absence of renin-like activity in rat aorta and microvessels. Hypertension. 1983 Sep-Oct;5(5):635–641. doi: 10.1161/01.hyp.5.5.635. [DOI] [PubMed] [Google Scholar]
  26. Ganong W. F. The brain renin-angiotensin system. Annu Rev Physiol. 1984;46:17–31. doi: 10.1146/annurev.ph.46.030184.000313. [DOI] [PubMed] [Google Scholar]
  27. Ganten D., Hermann K., Bayer C., Unger T., Lang R. E. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science. 1983 Aug 26;221(4613):869–871. doi: 10.1126/science.6879184. [DOI] [PubMed] [Google Scholar]
  28. Ganten D., Hermann K., Unger T., Lang R. E. The tissue renin-angiotensin systems: focus on brain angiotensin, adrenal gland and arterial wall. Clin Exp Hypertens A. 1983;5(7-8):1099–1118. doi: 10.3109/10641968309048844. [DOI] [PubMed] [Google Scholar]
  29. Gardes J., Bouhnik J., Clauser E., Corvol P., Menard J. Role of angiotensinogen in blood pressure homeostasis. Hypertension. 1982 Mar-Apr;4(2):185–189. doi: 10.1161/01.hyp.4.2.185. [DOI] [PubMed] [Google Scholar]
  30. Goldstone R., Martin K., Zipser R., Horton R. Evidence for a dual action of converting enzyme inhibitor on blood pressure in normal man. Prostaglandins. 1981 Oct;22(4):587–598. doi: 10.1016/0090-6980(81)90068-x. [DOI] [PubMed] [Google Scholar]
  31. Gunther S., Gimbrone M. A., Jr, Alexander R. W. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature. 1980 Sep 18;287(5779):230–232. doi: 10.1038/287230a0. [DOI] [PubMed] [Google Scholar]
  32. Haas E., Lewis L. V., Scipione P., Koshy T. J., Varde A. U., Renerts L. Angiotensin-producing enzyme I of serum: formation by immunization with renin. J Hypertens. 1984 Apr;2(2):131–140. doi: 10.1097/00004872-198404000-00003. [DOI] [PubMed] [Google Scholar]
  33. Haas E., Lewis L. V., Scipione P., Koshy T. J., Varde A. U., Renerts L. Angiotensin-producing serum enzyme II. Formation by inhibitor removal and proenzyme activation. Hypertension. 1985 Nov-Dec;7(6 Pt 1):938–947. doi: 10.1161/01.hyp.7.6.938. [DOI] [PubMed] [Google Scholar]
  34. Hackenthal E., Hackenthal R., Hilgenfeldt U. Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensin-forming enzymes. Biochim Biophys Acta. 1978 Feb 10;522(2):574–588. doi: 10.1016/0005-2744(78)90089-x. [DOI] [PubMed] [Google Scholar]
  35. Harris P. J., Navar L. G. Tubular transport responses to angiotensin. Am J Physiol. 1985 May;248(5 Pt 2):F621–F630. doi: 10.1152/ajprenal.1985.248.5.F621. [DOI] [PubMed] [Google Scholar]
  36. Hirose S., Kim S., Miyazaki H., Park Y. S., Murakami K. In vitro biosynthesis of human renin and identification of plasma inactive renin as an activation intermediate. J Biol Chem. 1985 Dec 25;260(30):16400–16405. [PubMed] [Google Scholar]
  37. Horky K., Rojo-Ortega J. M., Rodriguez J., Boucher R., Genest J. Renin, renin substrate, and angiotensin I-converting enzyme in the lymph of rats. Am J Physiol. 1971 Feb;220(2):307–311. doi: 10.1152/ajplegacy.1971.220.2.307. [DOI] [PubMed] [Google Scholar]
  38. Husain A., Smeby R. R., Wilk D., Dzau V. J., Bumpus F. M. Biochemical and immunological properties of dog brain isorenin. Endocrinology. 1984 Jun;114(6):2210–2215. doi: 10.1210/endo-114-6-2210. [DOI] [PubMed] [Google Scholar]
  39. Imai Y., Abe K., Seino M., Haruyama T., Tajima J., Sato M., Goto T., Hiwatari M., Kasai Y., Yoshinaga K. Attenuation of pressor responses to norepinephrine and pitressin and potentiation of pressor response to angiotensin II by captopril in human subjects. Hypertension. 1982 May-Jun;4(3):444–451. doi: 10.1161/01.hyp.4.3.444. [DOI] [PubMed] [Google Scholar]
  40. Inagami T. Renin in the brain and neuroblastoma cells: an endogenous and intracellular system. Neuroendocrinology. 1982 Dec;35(6):475–482. doi: 10.1159/000123425. [DOI] [PubMed] [Google Scholar]
  41. Johnston C. I., Millar J. A., McGrath B. P., Matthews P. G. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension. Lancet. 1979 Sep 8;2(8141):493–496. doi: 10.1016/s0140-6736(79)91552-6. [DOI] [PubMed] [Google Scholar]
  42. Kawamura M., Nakamaru M., Inagami T. Evidence for existence of angiotensins I and II in mature renin granules from rat kidney cortex. Biochem Biophys Res Commun. 1985 Sep 16;131(2):628–633. doi: 10.1016/0006-291x(85)91283-5. [DOI] [PubMed] [Google Scholar]
  43. Leckie B., Szelke M., Hallett A., Hughes M., Lever A. F., McIntyre G., Morton J. J., Tree M. Peptide inhibitors of renin. Clin Exp Hypertens A. 1983;5(7-8):1221–1236. doi: 10.3109/10641968309048853. [DOI] [PubMed] [Google Scholar]
  44. Levens N. R., Peach M. J., Carey R. M. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res. 1981 Feb;48(2):157–167. doi: 10.1161/01.res.48.2.157. [DOI] [PubMed] [Google Scholar]
  45. Lilly L. S., Pratt R. E., Alexander R. W., Larson D. M., Ellison K. E., Gimbrone M. A., Jr, Dzau V. J. Renin expression by vascular endothelial cells in culture. Circ Res. 1985 Aug;57(2):312–318. doi: 10.1161/01.res.57.2.312. [DOI] [PubMed] [Google Scholar]
  46. Lind R. W., Swanson L. W., Ganten D. Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. An immunohistochemical study. Neuroendocrinology. 1985 Jan;40(1):2–24. doi: 10.1159/000124046. [DOI] [PubMed] [Google Scholar]
  47. Loudon M., Bing R. F., Thurston H., Swales J. D. Arterial wall uptake of renal renin and blood pressure control. Hypertension. 1983 Sep-Oct;5(5):629–634. doi: 10.1161/01.hyp.5.5.629. [DOI] [PubMed] [Google Scholar]
  48. Man in 't Veld A. J., Wenting G. J., Schalekamp M. A. Does captopril lower blood pressure in anephric patients? Br Med J. 1979 Nov 3;2(6198):1110–1110. doi: 10.1136/bmj.2.6198.1110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Marks E. S., Bing R. F., Thurston H., Swales J. D. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat. Clin Sci (Lond) 1980 Jan;58(1):1–6. doi: 10.1042/cs0580001. [DOI] [PubMed] [Google Scholar]
  50. Maruta H., Arakawa K. Confirmation of direct angiotensin formation by kallikrein. Biochem J. 1983 Jul 1;213(1):193–200. doi: 10.1042/bj2130193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. McGiff J. C., Terragno N. A., Malik K. U., Lonigro A. J. Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circ Res. 1972 Jul;31(1):36–43. doi: 10.1161/01.res.31.1.36. [DOI] [PubMed] [Google Scholar]
  52. Menard J., Galen F. X., Devaux C., Kopp N., Auzan C., Corvol P. Immunochemical differences between angiotensin I-forming enzymes in man. Clin Sci (Lond) 1980 Dec;59 (Suppl 6):41s–44s. doi: 10.1042/cs059041s. [DOI] [PubMed] [Google Scholar]
  53. Miyamori I., Brown M. J., Dollery C. T. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin. Clin Exp Hypertens. 1980;2(6):935–945. doi: 10.3109/10641968009037152. [DOI] [PubMed] [Google Scholar]
  54. Morris B. J., Johnston C. I. Renin substrate in granules from rat kidney cortex. Biochem J. 1976 Mar 15;154(3):625–637. doi: 10.1042/bj1540625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Morton J. J., Tree M., Casals-Stenzel J. The effect of captopril on blood pressure and angiotensins I, II and III in sodium-depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme. Clin Sci (Lond) 1980 Jun;58(6):445–450. doi: 10.1042/cs0580445. [DOI] [PubMed] [Google Scholar]
  56. Nakamaru M., Jackson E. K., Inagami T. Beta-adrenoceptor-mediated release of angiotensin II from mesenteric arteries. Am J Physiol. 1986 Jan;250(1 Pt 2):H144–H148. doi: 10.1152/ajpheart.1986.250.1.H144. [DOI] [PubMed] [Google Scholar]
  57. Naruse K., Inagami T., Celio M. R., Workman R. J., Takii Y. Immunohistochemical evidence that angiotensins I and II are formed by intracellular mechanism in juxtaglomerular cells. Hypertension. 1982 May-Jun;4(3 Pt 2):70–74. [PubMed] [Google Scholar]
  58. Navar L. G., Rosivall L. Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics. Kidney Int. 1984 Jun;25(6):857–868. doi: 10.1038/ki.1984.102. [DOI] [PubMed] [Google Scholar]
  59. Ohkubo H., Nakayama K., Tanaka T., Nakanishi S. Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. J Biol Chem. 1986 Jan 5;261(1):319–323. [PubMed] [Google Scholar]
  60. Okamura T., Clemens D. L., Inagami T. Generation of angiotensins in cultured pheochromocytoma cells. Neurosci Lett. 1984 May 4;46(2):151–156. doi: 10.1016/0304-3940(84)90433-6. [DOI] [PubMed] [Google Scholar]
  61. Okamura T., Clemens D. L., Inagami T. Renin, angiotensins, and angiotensin-converting enzyme in neuroblastoma cells: evidence for intracellular formation of angiotensins. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6940–6943. doi: 10.1073/pnas.78.11.6940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Okunishi H., Miyazaki M., Toda N. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens. 1984 Jun;2(3):277–284. [PubMed] [Google Scholar]
  63. Oliver J. A., Sciacca R. R., Cannon P. J. Renal vasodilation by converting enzyme inhibition. Role of renal prostaglandins. Hypertension. 1983 Mar-Apr;5(2):166–171. doi: 10.1161/01.hyp.5.2.166. [DOI] [PubMed] [Google Scholar]
  64. Oliver J. A., Sciacca R. R. Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat. J Clin Invest. 1984 Oct;74(4):1247–1251. doi: 10.1172/JCI111534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Pandey K. N., Maki M., Inagami T. Detection of renin mRNA in mouse testis by hybridization with renin cDNA probe. Biochem Biophys Res Commun. 1984 Dec 14;125(2):662–667. doi: 10.1016/0006-291x(84)90590-4. [DOI] [PubMed] [Google Scholar]
  66. Pandey K. N., Misono K. S., Inagami T. Evidence for intracellular formation of angiotensins: coexistence of renin and angiotensin-converting enzyme in Leydig cells of rat testis. Biochem Biophys Res Commun. 1984 Aug 16;122(3):1337–1343. doi: 10.1016/0006-291x(84)91238-5. [DOI] [PubMed] [Google Scholar]
  67. Peach M. J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977 Apr;57(2):313–370. doi: 10.1152/physrev.1977.57.2.313. [DOI] [PubMed] [Google Scholar]
  68. Re R., Fallon J. T., Dzau V., Quay S. C., Haber E. Renin synthesis by canine aortic smooth muscle cells in culture. Life Sci. 1982 Jan 4;30(1):99–106. doi: 10.1016/0024-3205(82)90641-5. [DOI] [PubMed] [Google Scholar]
  69. Reilly C. F., Tewksbury D. A., Schechter N. M., Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem. 1982 Aug 10;257(15):8619–8622. [PubMed] [Google Scholar]
  70. Richoux J. P., Cordonnier J. L., Bouhnik J., Clauser E., Corvol P., Menard J., Grignon G. Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res. 1983;233(2):439–451. doi: 10.1007/BF00238309. [DOI] [PubMed] [Google Scholar]
  71. Sealey J. E., Atlas S. A., Laragh J. H. Prorenin and other large molecular weight forms of renin. Endocr Rev. 1980 Fall;1(4):365–391. doi: 10.1210/edrv-1-4-365. [DOI] [PubMed] [Google Scholar]
  72. Sealey J. E., White R. P., Laragh J. H., Rubin A. L. Plasma prorenin and renin in anephric patients. Circ Res. 1977 Oct;41(4 Suppl 2):17–21. doi: 10.1161/01.res.41.4.17. [DOI] [PubMed] [Google Scholar]
  73. Semple P. F., Boyd A. S., Dawes P. M., Morton J. J. Angiotensin II and its heptapeptide (2-8), hexapeptide (3-8), and pentapeptide (4-8) metabolites in arterial and venous blood of man. Circ Res. 1976 Nov;39(5):671–678. doi: 10.1161/01.res.39.5.671. [DOI] [PubMed] [Google Scholar]
  74. Shoback D. M., Williams G. H., Swartz S. L., Davies R. O., Hollenberg N. K. Time course and effect of sodium intake on vascular and hormonal responses to enalapril (MK 421) in normal subjects. J Cardiovasc Pharmacol. 1983 Nov-Dec;5(6):1010–1018. doi: 10.1097/00005344-198311000-00015. [DOI] [PubMed] [Google Scholar]
  75. Soubrier F., Devaux C., Galen F. X., Skinner S. L., Aurell M., Genest J., Menard J., Corvol P. Biochemical and immunological characterization of ectopic tumoral renin. J Clin Endocrinol Metab. 1982 Jan;54(1):139–144. doi: 10.1210/jcem-54-1-139. [DOI] [PubMed] [Google Scholar]
  76. Swales J. D., Abramovici A., Beck F., Bing R. F., Loudon M., Thurston H. Arterial wall renin. J Hypertens Suppl. 1983 Oct;1(1):17–22. [PubMed] [Google Scholar]
  77. Swales J. D. Arterial wall or plasma renin in hypertension? Clin Sci (Lond) 1979 Apr;56(4):293–298. doi: 10.1042/cs0560293. [DOI] [PubMed] [Google Scholar]
  78. Swartz S. L., Williams G. H., Hollenberg N. K., Levine L., Dluhy R. G., Moore T. J. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest. 1980 Jun;65(6):1257–1264. doi: 10.1172/JCI109788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Symonds E. M., Stanley M. A., Skinner S. L. Production of renin by in vitro cultures of human chorion and uterine muscle. Nature. 1968 Mar 23;217(5134):1152–1153. doi: 10.1038/2171152a0. [DOI] [PubMed] [Google Scholar]
  80. Taugner R., Hackenthal E., Helmchen U., Ganten D., Kugler P., Marin-Grez M., Nobiling R., Unger T., Lockwald I., Keilbach R. The intrarenal renin-angiotensin-system. An immunocytochemical study on the localization of renin, angiotensinogen, converting enzyme and the angiotensins in the kidney of mouse and rat. Klin Wochenschr. 1982 Oct 1;60(19):1218–1222. doi: 10.1007/BF01716726. [DOI] [PubMed] [Google Scholar]
  81. Textor S. C., Brunner H. R., Gavras H. Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanism. Hypertension. 1981 Mar-Apr;3(2):269–276. doi: 10.1161/01.hyp.3.2.269. [DOI] [PubMed] [Google Scholar]
  82. Thibonnier M., Aldigier J. C., Soto M. E., Sassano P., Menard J., Corvol P. Abnormalities and drug-induced alterations of vasopressin in human hypertension. Clin Sci (Lond) 1981 Dec;61 (Suppl 7):149s–152s. doi: 10.1042/cs061149s. [DOI] [PubMed] [Google Scholar]
  83. Thurston H., Swales J. D. Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor. Circ Res. 1978 May;42(5):588–592. doi: 10.1161/01.res.42.5.588. [DOI] [PubMed] [Google Scholar]
  84. Tonnesen M. G., Klempner M. S., Austen K. F., Wintroub B. U. Identification of a human neutrophil angiotension II-generating protease as cathepsin G. J Clin Invest. 1982 Jan;69(1):25–30. doi: 10.1172/JCI110437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Unger T., Ganten D., Lang R. E. Pharmacology of converting enzyme inhibitors: new aspects. Clin Exp Hypertens A. 1983;5(7-8):1333–1354. doi: 10.3109/10641968309048861. [DOI] [PubMed] [Google Scholar]
  86. Vecsei P., Hackenthal E., Ganten D. The renin-angiotensin-aldosterone system. Past, present and future. Klin Wochenschr. 1978;56 (Suppl 1):5–21. doi: 10.1007/BF01477448. [DOI] [PubMed] [Google Scholar]
  87. Waeber B., Gavras I., Brunner H. R., Cook C. A., Charocopos F., Gavras H. P. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity. Am Heart J. 1982 Mar;103(3):384–390. doi: 10.1016/0002-8703(82)90278-2. [DOI] [PubMed] [Google Scholar]
  88. Waite M. A. Measurement of concentrations of angiotensin I in human blood by radioimmunoassay. Clin Sci. 1973 Jul;45(1):51–64. doi: 10.1042/cs0450051. [DOI] [PubMed] [Google Scholar]
  89. Weinberger M. H. Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients. Am J Cardiol. 1982 Apr 21;49(6):1542–1543. doi: 10.1016/0002-9149(82)90383-6. [DOI] [PubMed] [Google Scholar]
  90. Williams G. H., Hollenberg N. K. Accentuated vascular and endocrine response to SQ 20881 in hypertension. N Engl J Med. 1977 Jul 28;297(4):184–188. doi: 10.1056/NEJM197707282970404. [DOI] [PubMed] [Google Scholar]
  91. Wood J. M., Gulati N., Forgiarini P., Fuhrer W., Hofbauer K. G. Effects of a specific and long-acting renin inhibitor in the marmoset. Hypertension. 1985 Sep-Oct;7(5):797–803. doi: 10.1161/01.hyp.7.5.797. [DOI] [PubMed] [Google Scholar]
  92. Yasujima M., Abe K., Tanno M., Kasai Y., Sato K., Tajima J., Kudo K., Tsunoda K., Yoshinaga K. Renal prostaglandin E in the hypotensive mechanism of MK-421 in conscious rats. J Hypertens. 1984 Dec;2(6):623–629. doi: 10.1097/00004872-198412000-00007. [DOI] [PubMed] [Google Scholar]
  93. Yasujima M., Matthews G., Johnston C. I. Decreased uterine bradykinin receptors during captopril infusion in rats. Am J Cardiol. 1982 Apr 21;49(6):1518–1520. doi: 10.1016/0002-9149(82)90374-5. [DOI] [PubMed] [Google Scholar]
  94. Yu R., Anderton J., Skinner S. L., Best J. B. Renin in anephric man. Case report with physiologic studies. Am J Med. 1972 May;52(5):707–711. doi: 10.1016/0002-9343(72)90061-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES